Emerging treatments are rapidly shifting the paradigm for metabolic dysfunction. MOTS-c, including various compounds , offer intriguing opportunities for addressing conditions like type second hyperglycemia and obesity . While research are ongoing , preliminary data indicate remarkable gains in glucose regulation and body reduction , sparking great